Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Tables)

v3.19.3.a.u2
Stock-based Compensation (Tables)
 12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Allocation of Stock-based Compensation Expense

The allocation of stock-based compensation expense between research and development and general and administrative expense was as follows:

 

    Year Ended  
    December 31,  
    2019     2018  
Research and Development   $ 113,239     $ -  
General and Administrative     397,239       74,063  
    $ 510,478     $ 74,063  

Schedule of Stock Option Valuation Assumption

The fair value of our option awards granted during the year ended December 31, 2019 and 2018 was estimated using the following assumptions:

 

    2019     2018  
Average risk-free rate of interest     1.85 %     3.09 %
Expected term (years)     3.75 to 5.00       5.00 to 6.25  
Expected stock price volatility     81.77 %     85.31 %
Dividend yield     0 %     0 %

Schedule of Stock Option

The following table summarizes our stock option activity for the year ended December 31, 2019 and 2018:

 

    Total options Outstanding     Weighted average exercise price     Weighted average remaining contractual life (in years)  
Outstanding as of January 1, 2018     -       -       -  
Options granted     54,915       20.45       9.8  
Exercised     -       -       -  
Forfeited     -          -       -  
Outstanding as of December 31, 2018     54,915     $ 20.45       9.8  
Options granted     129,919       16.80       4.5  
Exercised     -       -       -  
Forfeited     (7,872 )     16.80       4.5  
Outstanding as of December 31, 2019     176,962       17.93       5.8  
Exercisable (vested) at December 31, 2019     29,655       18.53       6.9